Tag: Intuniv

According to a 2024 study, up to 51% of adults with ADHD also suffer from co-morbid anxiety, making finding the right medication crucial. For those whose anxiety is worsened by stimulant medication, understanding what is the alternative to Adderall that doesn't cause anxiety is the first step toward effective treatment.

Studies show that between 5.6% and 37.9% of people with ADHD also have a comorbid anxiety disorder, making it a common and challenging combination. Addressing the question of **what ADHD medication stops anxiety?** requires understanding that some treatments can help manage both conditions, while others may exacerbate anxious symptoms.

Originally approved for treating hypertension in adults, the extended-release formulation of Guanfacine has since become an important non-stimulant medication for managing symptoms of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents. The medication, available under the brand names Tenex and Intuniv, acts on specific brain receptors to produce its therapeutic effects across different conditions.

While both Adderall and guanfacine are prescribed to treat Attention-Deficit/Hyperactivity Disorder (ADHD), they belong to entirely different classes of medication and have distinct mechanisms of action. In fact, the answer to **are Adderall and guanfacine the same thing?** is a definitive no, as one is a stimulant and the other is a non-stimulant.

Clinical trials and patient reports confirm that constipation is a common side effect of guanfacine, with studies indicating it affects up to 15% of users, especially with higher doses. This digestive issue can be frustrating, but understanding its cause and how to manage it can make a significant difference for those taking guanfacine.

Originally developed to treat high blood pressure, the drug guanfacine has since expanded its approved uses to include attention deficit hyperactivity disorder (ADHD) in children and adolescents. This non-stimulant medication works by affecting neurotransmitters in the brain to help regulate attention, impulsivity, and emotional responses.

According to a 2013 review in *Psychopharmacology*, atomoxetine was found to lack significant abuse potential, unlike traditional stimulants, highlighting what is the least addictive ADHD med. This is a crucial consideration for patients seeking effective treatment with minimal risk of dependency.

Originally approved in 1986 for high blood pressure, guanfacine is a prescription medication that has since gained approval for treating attention-deficit/hyperactivity disorder (ADHD). This guide explores what is guanfacine, detailing its mechanism, therapeutic uses, and key considerations for patients and caregivers.